FAM
BLCM

Fred Alger Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Fred Alger Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,800
Closed -$561K – 556
2017
Q2 		$561K Sell
4,800
-200
-4% -$24.8K ﹤0.01% 359
2017
Q1 		$617K Buy
5,000
+300
+6% +$39.3K ﹤0.01% 349
2016
Q4 		$640K Sell
4,700
-300
-6% -$53.3K ﹤0.01% 316
2016
Q3 		$995K Buy
5,000
+210
+4% +$36.2K 0.01% 309
2016
Q2 		$621K Buy
4,790
+830
+21% +$92.4K ﹤0.01% 360
2016
Q1 		$370K Sell
3,960
-200
-5% -$21.8K ﹤0.01% 434
2015
Q4 		$843K Buy
+4,160
New +$744K ﹤0.01% 395

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fred Alger Management's BLCM Position: Q3 2017 in Review

Fred Alger Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2017, closing a stake of 4,800 shares — an estimated $561K sold.

Fred Alger Management first reported a position in BLCM in Q4 2015 and held it in 7 quarters. The position peaked at $995K in Q3 2016. 88 funds tracked by Wall St. Rank hold BLCM as of Q3 2017.

  • Fred Alger Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Fred Alger Management sold 4,800 Bellicum Pharmaceuticals, Inc. shares in Q3 2017, an estimated $561K.
  • Fred Alger Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2015 and held it in 7 quarters.
  • Fred Alger Management's Bellicum Pharmaceuticals, Inc. position peaked at $995K in Q3 2016.
  • 88 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2017.

Based on Fred Alger Management's 13F filing for Q3 2017, filed 14 Nov 2017.